15-keto-Prostaglandin E

Animals Receptors, Prostaglandin E, EP2 Subtype / metabolism Zebrafish Endothelial Cells / metabolism Receptors, Prostaglandin E, EP4 Subtype Prostaglandins
15-keto-PGE(2) EP receptors Glomerular vascularization Podocytes Prostaglandins Zebrafish

Journal

Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521

Informations de publication

Date de publication:
01 Dec 2022
Historique:
received: 22 08 2022
revised: 06 10 2022
accepted: 17 10 2022
pubmed: 24 10 2022
medline: 15 11 2022
entrez: 23 10 2022
Statut: ppublish

Résumé

Prostaglandins are important signaling lipids with prostaglandin E Pharmacological treatment was performed in transgenic zebrafish embryos using 500 μM 15-keto-PGE Here, we show that 15-keto-PGE Altogether, our results reveal 15-keto-PGE

Identifiants

DOI: 10.1016/j.lfs.2022.121114 PMID: 36273629
pubmed: 36273629
pii: S0024-3205(22)00814-1
doi: 10.1016/j.lfs.2022.121114
pii:
doi:

Substances chimiques

Receptors, Prostaglandin E, EP2 Subtype 0
Receptors, Prostaglandin E, EP4 Subtype 0
Prostaglandins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121114

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Aikaterini Kourpa (A)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Buch, Berlin, Germany; Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.

Debora Kaiser-Graf (D)

Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.

Anje Sporbert (A)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Advanced Light Microscopy, Buch, Berlin, Germany.

Aurélie Philippe (A)

Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nephrology and Medical Intensive Care, Berlin, Germany; Berlin Institute of Health, Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, Berlin, Germany.

Rusan Catar (R)

Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nephrology and Medical Intensive Care, Berlin, Germany.

Michael Rothe (M)

Lipidomix GmbH, Berlin, Germany.

Eva Mangelsen (E)

Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.

Angela Schulz (A)

Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.

Juliane Bolbrinker (J)

Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.

Reinhold Kreutz (R)

Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.

Daniela Panáková (D)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Buch, Berlin, Germany. Electronic address: daniela.panakova@mdc-berlin.de.

Articles similaires

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Use of organic material provided by an automatic enrichment device by weaner pigs and its influence on tail lesions.

Philipp Heseker, Jeanette Probst, Stefanie Ammer et al.
1.00
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › 15-keto-Prostaglandin E
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs couplés aux protéines G › Récepteurs aux éicosanoïdes › Récepteur prostaglandine › Récepteur prostaglandine E › Sous-type EP2 des récepteurs des prostaglandines E › 15-keto-Prostaglandin E
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Poissons › Cypriniformes › Cyprinidae › Danio zébré › 15-keto-Prostaglandin E
questionsmedicales.fr › Cellules › Cellules épithéliales › Cellules endothéliales › 15-keto-Prostaglandin E
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs couplés aux protéines G › Récepteurs aux éicosanoïdes › Récepteur prostaglandine › Récepteur prostaglandine E › Sous-type EP4 des récepteurs des prostaglandines E › 15-keto-Prostaglandin E
questionsmedicales.fr › Facteurs biologiques › Médiateurs de l'inflammation › Autacoïdes › Éicosanoïdes › Prostaglandines › 15-keto-Prostaglandin E